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1 Introduction
This document is a supplementary to the paper: Neural networks for open and closed Literature based
discovery. It contains additional results and other details which were left out of the main paper to enhance
its clarity.
2 Formal Definitions of Evaluation Metrics
1. Mean Average Precision (MAP): Given a ranked list of predicted terms (C) relevant to a particular
query (A) term, we can calculate the precision after each true positive. The average of these values
gives the average precision for that query. This done over all queries gives a single value measure
which weights all queries (difficult or easy) equally.
MAP = ΣiAP (i)|V | ,
where |V | = number of queries, AP(i) = Σn(Rn − Rn−1)Pn and Pn and Rn are the Precision and
Recall at the nth threshold for the ith query.




where rank(i) = absolute rank for the ith query.
3. Averaged R(elevant)-Precision: Similar to MAP but instead of calculating the precision after
each positive term (gold C) in the list of results for a given query, precision is only calculated
with the top R results. R is determined by how many true positives exist for the query. The main
difference from MAP is that this metric does not consider the remainder of the ranked list outside
of the length of the top R. This also gives a single value measure which weights all queries equally.
This metric is similar to precision at k except that instead of having a fixed k, it changes based
on the amount of positives each node has so that a query with less than k positives is not unfairly
penalised and a query with a lot more positives than k is not easier for the approach to perform well
at.
AveragedR− precision = ΣiPr@R(i)|V | ,
where |V | = number of nodes, Pr@R(i) = precision at R for the ith node with R positives.
3 Other neural network hyperparameters
LINE: learning rate = 0.025, number of negative samples = 5 and total number of samples = 1 billion.
According to (Tang et al., 2015), LINE performs best when it is run twice to obtain first- and second-order
proximity embeddings which are concatenated and L2 normalized. I follow their recommendations. For
each order I created half the number of dimensions as needed so that when they were concatenated, the
final result had the appropriate number.
4 Node combination methods
A neural network approach to LBD with node embeddings requires the model input to be a single vector
so the embeddings of the nodes involved in a link need to be combined. This can be done in several ways.
Concatenating the embeddings is simple and preserves all information but doubles the size of the input.
(Grover and Leskovec, 2016) used four methods which preserve the input size and we experimented with
all five methods, detailed in Table 1.
Operator Definition
Average fi(u)+fi(v)2
Concatenate f(u) . f(v)
Hadamard fi(u) ∗ fi(v)
Weighted-L1 |fi(u)− fi(v)|
Weighted-L2 |fi(u)− fi(v)|2
Table 1: Node Combination methods. Binary operators are element-wise.
4.1 The LION Test Cases and Evaluation
These cases are described in detail in (Pyysalo et al., 2018). A condensed version is presented here for
completeness.
To identify discoveries, the cancer researchers involved in the project first surveyed articles published
between 2006 and 2016 in journals that publish works pertaining to biomolecular cancer, such as Science,
Nature, The Lancet, British Journal of Cancer, and Cell. In the initial pass, they sought to identify specific
cancer-related discoveries that can be characterized as a causal chain of three concepts, i.e. that fit the
constraints of the traditional ABC paradigm of LBD. This initial literature survey yielded 50 candidate
discoveries. The second stage filtered the candidates to identify discoveries that could have potentially
been found by LBD: the two connections A-B and B-C should be found in the literature at some point
in time before the connection between A and C is published. They identified cases where in some
year in the past, A-B and B-C each co-occurred in at least 100 publications but where no or very few
publications had A-C co-occur. To avoid possible bias towards a particular NLP methods or LBD tools
the filtering was performed manually using PubMed searches. In this manner the 50 candidates were
culled to 16 which were then assessed by all project participants. This yielded a final set of 5 triples that
represented specific recent discoveries on the molecular biology of cancer that could have potentially
been suggested by an LBD system prior to their publication. The ontology and database identifier in the
relevant resources were manually identified for each of the concepts in the dataset. In addition to these 5
cancer cases, in an effort to continue the trend of prior work, 5 cases from Swanson were also evaluated
by the system. Details of these can be found in Table 2 which is adapted from (Pyysalo et al., 2018).
5 Results
The results of the neural approaches are means of the means which were calculated over 5 runs. The
standard deviations reported are of the mean ranks. The results of the baselines are means of the method
across all relevant cases and the standard deviations are those over those ranks. The best rank is in
boldface type. We sought to determine what methods gave the lowest mean ranks and lowest variance
(measured by standard deviation). Where necessary, we use results from (Pyysalo et al., 2018).
Wherever there are models that do not use aggregators or accumulators, the results are simply placed
in the first column - this is merely for convenience, the column headers would not apply to such models.
The best for a particular approach is underlined while the best of all approaches is in bold.
There were some experiments which produced ties with the gold which were of an amount to make
them useless for real-world use. We defined that number as 10; methods which produced more than 10
ties with the gold are reported with a ’*’ instead of their performance.
A B C Reference
NF-κB Bcl-2 Adenoma (Van Der Heijden et al., 2016)
NOTCH1 senescence C/EBPβ (Hoare et al., 2016)
IL-17 p38α MKP-1 (Gaffen and McGeachy, 2015)
Nrf2 ROS pancreatic cancer (DeNicola et al., 2011)
CXCL12 senescence thyroid cancer (Kim et al., 2017)
Migraine - Magnesium (Swanson, 1988)
Somatomedin C - Arginine (Swanson, 1990)
Alzheimers Disease - Estrogen (Smalheiser and Swanson, 1996b)
Alzheimers Disease - Indomethacin (Smalheiser and Swanson, 1996a)
Schizophrenia - Calcium Independent (Smalheiser and Swanson, 1998)
Phospholipase A2
Table 2: The Cancer Discovery and Swanson cases used to evaluate the LION System.
5.1 Cancer Discoveries and Swanson Cases
Results for Closed Discovery performed on the 5 Cancer discovery cases on which LION was originally
evaluated are in Tables 3 and 4.
Results for Open Discovery performed on the 5 Cancer Discovery cases on which LION was evaluated
as reported in the paper. Means are in Table 5 and medians are in Table 6.
Results for Open Discovery performed on the 5 Swanson cases on which LION was evaluated. Means
are in Table 7 and medians are in Table 8.
Results for Open Discovery performed on the 5 Cancer and 5 Swanson cases on which LION was
evaluated. Means are in Table 9 and medians are in Table 10.
Approach Min Avg Max
NPMI 278.2 272.6 282.0
SCP 252.2 285 298.6
χ2 268.2 258.0 269.8
t-test 262.0 246.8 260.8
LLR 266.0 246.4 264.0
Jaccard 214.8 258.8 281.6
Count 233.2 249.6 245.2
Doc-count 236.8 224.4 222.2
CD-1-A 112.9 86.3 97.2
CD-1-C 151.2 94.5 89.7
CD-1-H 357.2 251.3 287.0
CD-1-W1 228.7 195.8 189.0
CD-1-W2 614.3 482.9 565.2
CD-2-A 86.9 - -
CD-2-C 48.7 - -
CD-2-H 143.1 - -
CD-2-W1 402.6 - -
CD-2-W2 63.8 - -
Table 3: Mean Ranks for Closed Discovery on the Cancer Discovery Cases
5.2 Published Interactions: BioGRID
The results of the BioGRID experiments are in the Tables 11 to 14. Each table is dedicated to a single
metric: Mean Rank (MR), Mean Reciprocal Rank (MRR), Mean Average Precision (MAP) and Mean
Relevance-precision (R-precision).
Due to rounding, some scores seem equal in the tables but are not. Where this occurs and involves a
best performer, the unrounded number was used to break the ties.
Approach Min Avg Max
NPMI 86.0 119.0 170.0
SCP 70.0 196.0 299.0
χ2 74.0 196.0 270.0
t-test 56.0 136.0 261.0
LLR 65.0 163.0 264.0
Jaccard 81.0 213.0 282.0
Count 245.0 181.0 245.0
Doc-count 231.0 169.0 222.0
CD-1-A 96.0 93.8 89.4
CD-1-C 158.6 36.4 38.8
CD-1-H 282.8 176.0 238.8
CD-1-W1 109.4 158.4 114.8
CD-1-W2 300.2 240.0 256.0
CD-2-A 52.4 - -
CD-2-C 42.0 - -
CD-2-H 62.2 - -
CD-2-W1 180.6 - -
CD-2-W2 48.8 - -
Table 4: Median Ranks for Closed Discovery on the Cancer Discovery Cases
Approach Min Avg Max
Sum Max Sum Max Sum Max
NPMI 73,670.4 14,658.8 310.2 11,354.6 60.2 3479.2
SCP 244.8 2,358.4 553.8 1,408.4 556.0 1,305.4
χ2 37,387.4 2,971.6 603.4 1,521.2 601.4 1,469.6
t-test 118,606.8 465.6 73,657.2 559.2 126.0 825.0
LLR 73,715.0 649.4 253.0 1,011.8 280.4 1,870.8
Jaccard 89.2 1,741.8 121.2 952.6 136.2 1,186.0
Count 367.4 2,063.6 412.6 1,483.6 421.0 875.8
Doc-count 394.4 2,141.8 472.6 1,249.2 490.6 2,071.2
OD-1-A 218.3 * 239.1 2,098.0 264.2 *
OD-1-C 93.4 * 123.2 37,248.0 156.9 *
OD-1-H 257.9 4,762.6 270.6 7,820.9 280.6 *
OD-1-W1 212.2 14,932.1 225.1 23,456.7 236.7 *
OD-1-W2 247.8 8,777.7 281.48 20,546.9 311.9 *
OD-2-A 127.9 - - - - -
OD-2-C 95,207.6 - - - - -
OD-2-H 31.1 - - - - -
OD-2-W1 57,226.2 - - - - -
OD-2-W2 586.6 - - - - -
Table 5: Mean Ranks for Open Discovery on the Cancer Discovery Cases
6 Additional Analyses
The existing approaches performed much better on mean rank for open discovery than they did on closed
discovery, so there was more room for improvement there. This lower baseline explains to some degree
why the performance improvements were more pronounced for closed discovery (Table 3).
The difference between mean and median as average shows across the various cancer and Swanson
discovery cases: with the exception of open discovery on only the Cancer Discovery cases (Tables 5 and
Approach Min Avg Max
Sum Max Sum Max Sum Max
NPMI 98,698.0 15,476.0 121.0 5,897.0 36.0 2,268.0
SCP 276.0 926.0 400.0 1,176.0 399.0 727.0
χ2 547.0 3,582.0 402.0 1,159.0 402.0 1,159.0
t-test 118,751.0 63.0 98,406.0 325.0 125.0 176.0
LLR 98,677.0 187.0 344.0 646.0 319.0 645.0
Jaccard 29.0 1,089.0 78.0 962.0 93.0 1,122.0
Count 15.0 1,005.0 55.0 52.0 62.0 54.0
Doc-count 23.0 738.0 72.0 68.0 74.0 68.0
OD-1-A 26.8 * 38.6 1,212.6 48.6 *
OD-1-C 31.4 * 32.0 30,573.2 34.4 *
OD-1-H 46.2 1,750.3 46.6 8,120.4 49.4 *
OD-1-W1 28.6 8,905.0 33.4 21,335.2 39.2 *
OD-1-W2 43.8 8,370.2 49.0 18,442.8 55.2 *
OD-2-A 16.3 - - - - -
OD-2-C 98,148.2 - - - - -
OD-2-H 12.2 - - - - -
OD-2-W1 37,268.6 - - - - -
OD-2-W2 147.0 - - - - -
Table 6: Median Ranks for Open Discovery on the Cancer Discovery Cases
Approach Min Avg Max
Sum Max Sum Max Sum Max
NPMI 39,481.0 12,805.6 27,041.8 13,290.0 4480.4 10,568.6
SCP 4,498.8 7,666.0 5,154.8 3,024.0 5,174.8 2,700.4
χ2 37,873.6 10,402.8 5,182.6 4,702.8 5,319.6 3,803.2
t-test 46,240.0 7,076.2 37,344.2 7,989.2 3,956.4 6,756.2
LLR 37,440.8 6,761.6 3,286.6 2,663.0 4,367.4 2,691.0
Jaccard 3,179.6 3,629.2 4,342.8 4,105.4 4,455.2 3,878.8
Count 3,484.2 2,882.2 4,242.0 2,216.0 4,265.2 5,364.4
Doc-count 3,470.8 2,871.0 4,229.6 2,199.8 4,255.6 5,365.2
OD-1-A 3,643.0 6,468.8 3,726.7 7,405.2 3,805.3 *
OD-1-C 3,721.4 11,229.8 3,757.4 16,325.9 3,788.6 *
OD-1-H 3,558.3 * 3,618.0 5,427.8 3,666.5 *
OD-1-W1 3,752.8 * 3,928.6 12,814.2 4,058.1 *
OD-1-W2 3,746.7 10,100.4 4,091.0 12,183.3 4,345.4 *
OD-2-A 6,859.0 - - - - -
OD-2-C 38,639.0 - - - - -
OD-2-H 1,013.4 - - - - -
OD-2-W1 29,960.9 - - - - -
OD-2-W2 14,697.4 - - - - -
Table 7: Mean Ranks for Open Discovery on the Swanson Discovery Cases
6), the best performer for mean and median were different.
A conclusion to be drawn from all the results tables is that although the best neural network-based
approaches performed the best, simply using neural networks is not sufficient to produce the best results
as there are several instances where the best existing approaches outperformed some neural approaches.
Approach Min Avg Max
Sum Max Sum Max Sum Max
NPMI 41,837.0 8,869.0 16,714.0 9715.0 74.0 5,545.0
SCP 124.0 427.0 154.0 250.0 154.0 250.0
χ2 37,827.0 7,820.0 156.0 263.0 155.0 263.0
t-test 40,103.0 1,808.0 37,368.0 116.0 5.0 105.0
LLR 37,820.0 3,404.0 9.0 45.0 10.0 43.0
Jaccard 6.0 1,075.0 6.0 237.0 9.0 240.0
Count 8.0 43.0 20.0 29.0 21.0 261.0
Doc-count 7.0 21.0 20.0 31.0 21.0 237.0
OD-1-A 18.4 4,852.3 16.2 6,776.2 18.6 *
OD-1-C 4.0 1,917.8 9.6 6,933.0 16.4 *
OD-1-H 19.2 * 14.2 6,173.2 13.4 *
OD-1-W1 17.6 * 19.8 1,907.2 20.4 *
OD-1-W2 25.0 2,570.6 22.6 2,546.6 21.8 *
OD-2-A 605.4 - - - - -
OD-2-C 37,783.8 - - - - -
OD-2-H 17.6 - - - - -
OD-2-W1 44,254.0 - - - - -
OD-2-W2 49.6 - - - - -
Table 8: Median Ranks for Open Discovery on the Swanson Discovery Cases
Approach Min Avg Max
Sum Max Sum Max Sum Max
NPMI 56,575.7 13,732.2 13,676 12,322.3 2,270.3 7,023.9
SCP 2,371.8 5,012.2 2,854.3 2,216.2 2,865.4 2,002.9
χ2 37,630.5 6,687.2 2,893.0 3,112.0 2,960.5 2,636.4
t-test 82,423.4 3,770.9 55,500.7 4,274.2 2,041.2 3,790.6
LLR 55,577.9 3,705.5 1,769.8 1,837.4 2,323.9 2,280.9
Jaccard 1,634.4 2685.5 2,232.0 2,529.0 2,295.7 2,532.4
Count 1,925.8 2,472.9 2,327.3 1,849.8 2,343.1 3,120.1
Doc-count 1,932.0 2,506.4 2,351.1 1,724.5 2,373.1 3,718.2
OD-1-A 1,930.7 * 1,982.9 4,751.6 2,034.8 *
OD-1-C 1,907.42 * 1,940.3 26,786.9 1,972.8 *
OD-1-H 1,908.08 * 1,944.28 6,624.36 1,973.5 *
OD-1-W1 1,982.5 * 2,076.86 18,135.42 2,147.4 *
OD-1-W2 1,997.3 9,439.0 2,186.2 16,365.1 2,328.7 *
OD-2-A 3,493.5 - - - - -
OD-2-C 66,923.3 - - - - -
OD-2-H 522.2 - - - - -
OD-2-W1 43,593.5 - - - - -
OD-2-W2 7,642.0 - - - - -
Table 9: Mean Ranks for Open Discovery on the all Cases
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Approach Min Avg Max
Sum Max Sum Max Sum Max
NPMI 50,347.0 10,624.0 698.0 9,472.0 55.0 3,630.0
SCP 200.0 758.5 370.5 9,472.0 371.0 630.0
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